689PPhase II trial of preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by postoperative gemcitabine (GEM) in patients (pts) with borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)
Jeong, J H, Yoo, C, Kim, K-P, Chang, H-M, Ryoo, B-YVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.016
Date:
October, 2019
File:
PDF, 78 KB
2019
File converter
More search results
More benefits 
